NEW YORK (GenomeWeb News) – Nanogen disclosed in a regulatory filing with the US Securities and Exchange Commission today that it will restate its net loss for the first quarter of 2008 due to an accounting error.
 
As a result of the restatement, Nanogen’s net loss for the quarter ended March 31 will be $26.4 million rather than the $23 million it previously recorded.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.